Related Experiment Videos
Contemporary management of depression
1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322-4990.
The American Journal of Medicine
|December 19, 1994
Summary
Major depression is a treatable disorder, with antidepressants like SSRIs offering effective relief. Different antidepressants vary mainly in their side-effect profiles, guiding treatment choices for patients.
Area of Science:
- Pharmacology
- Psychiatry
- Neuroscience
Background:
- Major depression is a prevalent and debilitating condition with significant societal and economic impact.
- Current antidepressant treatments demonstrate response rates of 65-70%.
Purpose of the Study:
- To review the efficacy and side-effect profiles of various antidepressant classes.
- To inform clinical decision-making regarding antidepressant selection.
Main Methods:
- Literature review of major antidepressant classes including TCAs, MAOIs, and SSRIs.
- Analysis of reported side effects and drug interactions for each class.
Main Results:
- Selective serotonin reuptake inhibitors (SSRIs) offer effective treatment with a common side-effect profile of headache, nausea, and sexual dysfunction.
- Tricyclic antidepressants (TCAs) are effective but carry risks of cardiotoxicity and fatal overdoses.
- Monoamine oxidase inhibitors (MAOIs) have roles in specific depression subtypes but are limited by adverse effects and interactions.
Conclusions:
- Antidepressants are generally equally effective, with side-effect profiles being the primary differentiator.
- Individual SSRIs like fluoxetine, sertraline, and paroxetine have distinct side-effect profiles.
- Ongoing research into depression pathophysiology promises development of more targeted and better-tolerated antidepressants.